# EDGAR Filing Document

**Accession Number:** 0001463459
**File Stem:** 0000000000-23-000148
**Filing Date:** 2023-1
**Character Count:** 3811
**Document Hash:** b8f71a4c2d01b201a074fefd38a6c2c9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-000148.hdr.sgml**: 20230207

**ACCESSION NUMBER**: 0000000000-23-000148

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230105

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Emergent Health Corp.
- **CENTRAL INDEX KEY:** 0001463459
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
- **IRS NUMBER:** 208944630
- **STATE OF INCORPORATION:** WY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 10120 VALLEY FORGE CIRCLE
- **CITY:** KING OF PRUSSIA
- **STATE:** PA
- **ZIP:** 19406
- **BUSINESS PHONE:** 484-518-9000

**MAIL ADDRESS:**
- **STREET 1:** 10120 VALLEY FORGE CIRCLE
- **CITY:** KING OF PRUSSIA
- **STATE:** PA
- **ZIP:** 19406

## Text-Extract

```

United States securities and exchange commission logo

                           January 5, 2023

       James Morrison
       Chief Executive Officer
       Emergent Health Corp.
       50 Motor Parkway, Suite 401
       Hauppauge, New York 11787

                                                        Re: Emergent Health
Corp.
                                                            Offering Statement
on Form 1-A
                                                            Post-qualification
Amendment No. 2
                                                            Filed January 3,
2023
                                                            File No. 024-11708

       Dear James Morrison:

                                                        This is to advise you
that we do not intend to review your amendment.

               We will consider qualifying your offering statement at your
request. If a participant in
       your offering is required to clear its compensation arrangements with
FINRA, please have
       FINRA advise us that it has no objections to the compensation
arrangements prior to
       qualification.

               We remind you that the company and its management are
responsible for the accuracy
       and adequacy of their disclosures, notwithstanding any review, comments,
action or absence of
       action by the staff.

                                                        Please contact Jennie
Beysolow at 202-551-8108 with any questions.

                           Sincerely,

                           Division of Corporation Finance

                           Office of Trade & Services
       cc:                                              Eric Newlan

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

DIVISION OF
CORPORATION FINANCE

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

January 5, 2023

James Morrison
Chief Executive Officer
Emergent Health Corp.
50 Motor Parkway, Suite 401
Hauppauge, New York 11787

**Re: Emergent Health Corp.**
**Offering Statement on Form 1-A**
**Post-qualification Amendment No. 2**
**Filed January 3, 2023**
**File No. 024-11708**

Dear James Morrison:

This is to advise you that we do not intend to review your amendment.

We will consider qualifying your offering statement at your request. If a participant in your offering is required to clear its compensation arrangements with FINRA, please have FINRA advise us that it has no objections to the compensation arrangements prior to qualification.

We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Jennie Beysolow at 202-551-8108 with any questions.

Sincerely,

Division of Corporation Finance
Office of Trade & Services

cc: Eric Newlan